Clearmind Medicine Inc.
CMND· Nasdaq
CMNDClearmind Medicine Inc.
Source filing unavailable
| Metric | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|
| Net Income | -$3.85M | -$1.07M | -$1.37M |
| EPS Diluted | -$3.32 | -$0.24 | -$0.90 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Clearmind Medicine Inc. · CIK 1892500 · Engraved from SEC EDGAR
